Innocan, Pharma

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Innocan Pharma Corporation Canada Ontario Israel

en | boerse | 67955290 |